SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-244555
Filing Date
2018-08-09
Accepted
2018-08-09 17:17:57
Documents
56
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d617111d10q.htm 10-Q 376555
2 EX-10.4 d617111dex104.htm EX-10.4 14484
3 EX-31.1 d617111dex311.htm EX-31.1 7464
4 EX-32.1 d617111dex321.htm EX-32.1 3693
  Complete submission text file 0001193125-18-244555.txt   3460257

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT zsan-20180630.xml EX-101.INS 697733
6 XBRL TAXONOMY EXTENSION SCHEMA zsan-20180630.xsd EX-101.SCH 41754
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zsan-20180630_cal.xml EX-101.CAL 54603
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zsan-20180630_def.xml EX-101.DEF 129345
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE zsan-20180630_lab.xml EX-101.LAB 364330
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zsan-20180630_pre.xml EX-101.PRE 253017
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36570 | Film No.: 181006357
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences